Preprints – versions of manuscripts posted on public servers before formal peer review – are shaking up the world of bioscience publishing, and they have been crucial during the COVID-19 pandemic for sharing results rapidly and widely. However, despite their benefits, the use of preprint servers for sharing pharma-funded research remains low.
To address this issue, we have created a new educational resource that explores how and why preprint servers are a valuable tool for disseminating pharma research. The resource covers:
- the different types of preprint servers available
- the benefits of sharing pharma research before peer review
- the potential risks of sharing pharma research through preprint servers and how to mitigate them.
Check out the resource on our website and our figshare page. If you have any feedback, we’d love to hear from you! Get in touch with us here.